pharma · Weight management · Short Bowel Syndrome
Zealand Pharma
Zealand Pharma A/S
Zealand Pharma A/S is a pharma organization headquartered in EU. Primary therapeutic focus areas include Weight management, Short Bowel Syndrome, Children with congenital hyperinsulinism, Critically Ill, Mechanically Ven
Company details
- Status
- Public
- HQ
- Sydmarken 11, Søborg (Copenhagen), 2860, DK
- Founded
- 1998
- Employees
- 596
- Programs
- 18
- Drugs
- 20
- Patents
- 0
Quick answer
Zealand Pharma A/S is a pharma organization headquartered in EU. Primary therapeutic focus areas include Weight management, Short Bowel Syndrome, Children with congenital hyperinsulinism, Critically Ill, Mechanically Ventilated, Rhabdoid Tumor. NovaPharmaNews links 18 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.gov, and USPTO sources. Pipeline phase mix: phase 3 (7), phase 1 (5), phase 2 (5).
Company snapshot
Zealand Pharma A/S is a [Danish](en.wikipedia.org/wiki/Denmark) [biotechnology](en.wikipedia.org/wiki/Biotechnology) research company, which designs and develops [peptide-based](en.wikipedia.org/wiki/Peptide) medicines, mainly focusing on [metabolic diseases](en.wikipedia.org/wiki/Metabolic_diseases) like [diabetes](en.wikipedia.org/wiki/Diabetes) and [obesity](en.wikipedia.org/wiki/Obesity). The
- 18 active pipeline program(s) linked via ClinicalTrials.gov.
- 18 trial update(s) in the last 12 months.
Public regulatory, clinical, patent, and corporate records for Zealand Pharma. Not investment advice.
Catalysts
Upcoming readouts, regulatory dates, and congress activity.
- approval
Ten-Year-Old Cambridge Biotech Seeks Merger or Acquisition Amidst Market Pressures
Recent coverage
Top assets
Lead pipeline drugs
- Marketed / approved
- Marketed / approved
- approved
- Marketed / approved
Active clinical programs
- Phase 3
- Phase 3
- Phase 3
- Phase 3
Momentum
Proprietary activity score for Zealand Pharma.
2 active signals
Signal breakdown
- Clinical trials
- Nova articles
- Patents filed
- FDA actions
- SEC filings
- Conference presentations
- Pipeline advances
Recent activity
Latest pipeline, patent, and corporate events for Zealand Pharma.
- Clinical update
- Clinical update
- Clinical update
- Clinical update
- Clinical update
Quick answers
Common questions about this sponsor — for analysts and search.
-
What is Zealand Pharma?
-
Is Zealand Pharma publicly traded?
-
What drugs does Zealand Pharma develop or market?
-
What are the latest developments for Zealand Pharma?
-
What therapeutic areas does Zealand Pharma focus on?
Therapeutic focus
Therapeutic area distribution
Pipeline concentration by therapeutic area from linked clinical programs.